Method of administering a vaccine comprising tritrichomonas foetus membrane surface antigens between 45 and 300 kilopaltons
AssigneeProtaTek International, Inc.
InventorsMiodrag Ristic, Lionel Wanduragala
Life of this patent
Estimating the term…
Abstract
A subunit vaccine for Tritrichomonas foetus and method for preparing such vaccine for use in immunizing and treating animals is provided. The method disclosed involves separating out the antigens by centrifuging homogenized Tritrichomonas foetus cells, preferably at about 830.times.g for about 15 minutes, solubilizing the antigen with an nonionic detergent and completing with saponin. Topical administration, such as intravaginal or intrapretutial administration, of such vaccine preparation in conjunction with subcutaneous administration in combination with other adjuvants is effective to eliminate infection.
Claims6
A method for treating, Tritrichomonas foetus infection, or immunizing to prevent Tritrichomonas foetus infection in a male or female bovine, the method comprising:
- (a) administering to the male or female bovine an effective amount of an inactivated vaccine composition to treat or to immunize to prevent Tritrichomonas foetus infection such that:
- (i) the vaccine composition is administered to a male bovine by an intrapreputial and a parenteral route;
- or
- (ii) the vaccine composition is administered to a female bovine by an intravaginal and a parenteral route
- wherein said vaccine composition comprises a saponin and a subunit fraction of Tritrichomonas foetus membrane surface antigens of molecular weights between 45 and 300 kD.
A method for immunizing to prevent Tritrichomonas foetus infection in a male or female bovine, the method comprising:
- (a) administering to the male or female bovine an effective amount of an inactivated vaccine composition to prevent Tritrichomonas foetus infection such that:
- (i) the vaccine composition is administered to a male bovine by an intrapreputial route;
- or
- (ii) the vaccine composition is administered to a female bovine by an intravaginal route
- wherein said vaccine composition comprises a saponin and a subunit fraction of Tritrichomonas foetus membrane surface antigens of molecular weights between 45 and 300 kD.
Dependencies are inferred from the claim text.